Literature DB >> 15572814

Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia.

Feyzullah Cetinkaya1, Abdulkadir Gogremis, Gunsel Kutluk.   

Abstract

OBJECTIVE: The diagnosis and the treatment of community-acquired severe pneumonia is still a serious child health problem in developing countries. The aim of this study is to evaluate the effectiveness of two different antibiotic regimens in the empirical treatment of severe childhood pneumonia.
METHODOLOGY: We enrolled 97 infants (aged 2-24 months) with severe community-acquired pneumonia in a randomized-controlled trial of 10 days of treatment with penicillin G+chloramphenicol (n:46) or ceftriaxone (n:51). We evaluated the effectiveness of treatments with symptoms and some laboratory tests during and at the end of the study.
RESULTS: The cure rates were similar in both groups and the antibiotic regimens in all patients were found effective (P< 0.001). The number of nurse rounds was much more in penicillin plus chloramphenicol group than ceftriaxone group.
CONCLUSION: Both penicillin G plus chloramphenicol and ceftriaxone are effective in the empirical treatment of severe community pneumonia of young children. In spite of more nurse visits for antibiotic treatment, penicillin G+ chloramphenicol combination may be a cheaper alternative to ceftriaxone in the treatment of childhood pneumonia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572814     DOI: 10.1007/bf02828108

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  14 in total

Review 1.  Community-acquired pneumonia in children.

Authors:  Kenneth McIntosh
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

2.  The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries.

Authors:  M Garenne; C Ronsmans; H Campbell
Journal:  World Health Stat Q       Date:  1992

3.  Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D J Hoban; G V Doern; A C Fluit; M Roussel-Delvallez; R N Jones
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

4.  A practical guide for the diagnosis and treatment of pediatric pneumonia.

Authors:  T Jadavji; B Law; M H Lebel; W A Kennedy; R Gold; E E Wang
Journal:  CMAJ       Date:  1997-03-01       Impact factor: 8.262

5.  Etiology of severe pneumonia in children in developing countries.

Authors:  F Shann
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr

6.  Characterization of haemophilus influenzae isolated from invasive disease in Brazil from 1990 to 1999.

Authors:  Rosemeire C Zanella; Silvana T Casagrande; Sérgio Bokermann; Samanta C G Almeida; Maria Cristina C Brandileone
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

7.  The management of pneumonia in children in developing countries.

Authors:  F Shann
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

8.  Pneumonia: antimicrobial therapy for infants and children.

Authors:  D Teele
Journal:  Pediatr Infect Dis       Date:  1985 May-Jun

9.  Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission.

Authors:  F Shann; K Hart; D Thomas
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

10.  The role of viruses and Mycoplasma pneumoniae in lower respiratory tract infections in childhood.

Authors:  A Göçmen; F Cetinkaya; S Ustaçelebi; D Us
Journal:  Turk J Pediatr       Date:  1992 Apr-Jun       Impact factor: 0.552

View more
  2 in total

Review 1.  Antibiotics for community-acquired pneumonia in children.

Authors:  Rakesh Lodha; Sushil K Kabra; Ravindra M Pandey
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

Review 2.  Experience developing national evidence-based clinical guidelines for childhood pneumonia in a low-income setting--making the GRADE?

Authors:  Ambrose Agweyu; Newton Opiyo; Mike English
Journal:  BMC Pediatr       Date:  2012-01-01       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.